Data indicate that participants receiving oral amycretin achieved an average weight loss of 13.1% after 12 weeks, which is substantially greater than the 1.1% weight loss observed in the placebo group [128]
Limitations of AI in psychiatric research Despite the promising potential of AI in psychiatric research, challenges such as data heterogeneity, ethical considerations, overfitting, interpretability and the necessity for more extensive, robust studies persist and must be addressed to fully integrate AI into clinical practice (Barberis et al
At the same time, the medication acts on receptors in the hypothalamus, the brains appetite control centre, dampening the drive to seek out food and increasing the sense of satisfaction from smaller portions
Obesity, alcohol consumption and hypertension (binary variables) were defined by any diagnosis codes related to the conditions in question and/or ever use of medications for their treatment
Potential long-term risks if unsupervised, including overstimulation of hormone pathways